Search research articles
Contact Us
Filters
Showing results (61-70 of 115) with videos related to
Page
of 12
Sort By:
Nature Communications
|
May 16, 2020
Publisher Correction: A human monoclonal antibody blocking SARS-CoV-2 infection
Chunyan Wang, Wentao Li, Dubravka Drabek, et al.
Nature Communications
|
June 22, 2024
Neutralizing antibodies reveal cryptic vulnerabilities and interdomain crosstalk in the porcine deltacoronavirus spike protein
Wenjuan Du, Oliver Debski-Antoniak, Dubravka Drabek, et al.
Plos Pathogens
|
August 10, 2023
Glycosylated extracellular mucin domains protect against SARS-CoV-2 infection at the respiratory surface
Maitrayee Chatterjee, Liane Z X Huang, Anna Z Mykytyn, et al.
Plos Pathogens
|
November 7, 2014
Coronavirus cell entry occurs through the endo-/lysosomal pathway in a proteolysis-dependent manner
Christine Burkard, Monique H Verheije, Oliver Wicht, et al.
Emerging Microbes & Infections
|
July 16, 2025
Identification of β4GALNT2 as an anti-hPIV3 factor through genome-wide CRISPR/Cas9 library screening
Xuesheng Wu, Rutger D Luteijn, Estefanía Lozano-Andrés, et al.
Plos Pathogens
|
March 23, 2026
AI-guided prefusion stabilization of the human coronavirus OC43 spike protein enables universal embecovirus antigen design
Jelle M Melchers, Jarek Juraszek, Ruben J G Hulswit, et al.
Emerging Microbes & Infections
|
August 22, 2020
Accurate serology for SARS-CoV-2 and common human coronaviruses using a multiplex approach
Sophie van Tol, Ramona Mögling, Wentao Li, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 20, 2004
Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides
Berend Jan Bosch, Byron E E Martina, Ruurd Van Der Zee, et al.
The Journal of Biological Chemistry
|
December 13, 2005
SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells
I-Chueh Huang, Berend Jan Bosch, Fang Li, et al.
Journal of Nanobiotechnology
|
March 10, 2025
A bivalent spike-targeting nanobody with anti-sarbecovirus activity
Iris C Swart, Oliver J Debski-Antoniak, Aneta Zegar, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 115) with videos related to
Sort By:
Page
of 12
Nature Communications
|
May 16, 2020
Publisher Correction: A human monoclonal antibody blocking SARS-CoV-2 infection
Chunyan Wang, Wentao Li, Dubravka Drabek, et al.
Nature Communications
|
June 22, 2024
Neutralizing antibodies reveal cryptic vulnerabilities and interdomain crosstalk in the porcine deltacoronavirus spike protein
Wenjuan Du, Oliver Debski-Antoniak, Dubravka Drabek, et al.
Plos Pathogens
|
August 10, 2023
Glycosylated extracellular mucin domains protect against SARS-CoV-2 infection at the respiratory surface
Maitrayee Chatterjee, Liane Z X Huang, Anna Z Mykytyn, et al.
Plos Pathogens
|
November 7, 2014
Coronavirus cell entry occurs through the endo-/lysosomal pathway in a proteolysis-dependent manner
Christine Burkard, Monique H Verheije, Oliver Wicht, et al.
Emerging Microbes & Infections
|
July 16, 2025
Identification of β4GALNT2 as an anti-hPIV3 factor through genome-wide CRISPR/Cas9 library screening
Xuesheng Wu, Rutger D Luteijn, Estefanía Lozano-Andrés, et al.
Plos Pathogens
|
March 23, 2026
AI-guided prefusion stabilization of the human coronavirus OC43 spike protein enables universal embecovirus antigen design
Jelle M Melchers, Jarek Juraszek, Ruben J G Hulswit, et al.
Emerging Microbes & Infections
|
August 22, 2020
Accurate serology for SARS-CoV-2 and common human coronaviruses using a multiplex approach
Sophie van Tol, Ramona Mögling, Wentao Li, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 20, 2004
Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides
Berend Jan Bosch, Byron E E Martina, Ruurd Van Der Zee, et al.
The Journal of Biological Chemistry
|
December 13, 2005
SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells
I-Chueh Huang, Berend Jan Bosch, Fang Li, et al.
Journal of Nanobiotechnology
|
March 10, 2025
A bivalent spike-targeting nanobody with anti-sarbecovirus activity
Iris C Swart, Oliver J Debski-Antoniak, Aneta Zegar, et al.
Page
of 12